EUVIMEDEUVIMED entdecken
Crossref

Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice

Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, Celso Martins Queiroz-Junior, Franciel Batista Félix, Letícia Cassiano Resende, Felipe Rocha da Silva Santos, Larisse de Souza Barbosa Lacerda, Victor Rodrigues de Melo Costa, Walison Nunes da Silva, Pedro Pires Goulart Guimaraes, Goulart Guimaraes und 4 weitere

Inflammation Research · 2025-12 · 74 (1)

DOI: 10.1007/s00011-024-01985-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation Research, online erschienen am 25.01.2025. Verfasst von Vinícius Amorim Beltrami und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil. Hauptthemen laut MEDLINE: Benzamides, Phosphodiesterase 4 Inhibitors, Aminopyridines, Lung Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: We aimed to understand the potential therapeutic and anti-inflammatory effects of the phosphodiesterase-4 (PDE4) inhibitor roflumilast in models of pulmonary infection caused by betacoronaviruses. METHODS: Mice were infected intranasally with murine hepatitis virus (MHV-3) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Roflumilast was given to MHV-3-infected mice therapeutically at doses of 1 mg/kg or 10 mg/kg, or prophylactically at 10 mg/kg. In SARS-CoV-2-infected mice, roflumilast was given therapeutically at a dose of 10 mg/kg. Lung histopathology, chemokines (CXCL-1 and CCL2), cytokines (IL-1β, IL-6, TNF, IFN-γ, IL-10 and TGFβ), neutrophil immunohistochemical staining (Ly6G+ cells), macrophage immunofluorescence staining (F4/80+ cells), viral titration plaque assay, real-time PCR virus detection, and blood cell counts were examined. RESULTS: Therapeutic treatment with roflumilast at 10 mg/kg reduced lung injury in SARS-CoV-2 or MHV-3-infected mice without compromising viral clearance. In MHV-3-infected mice, reduced lung injury was associated with decreased chemokines levels, prevention of neutrophil aggregates and reduced macrophage accumulation in the lung tissue. However, the prophylactic treatment strategy with roflumilast increased lung injury in MHV-3-infected mice. CONCLUSION: Our findings indicate that therapeutic treatment with roflumilast reduced lung injury in MHV-3 and SARS-CoV-2 lung infections. Given the protection induced by roflumilast in inflammation, PDE4 targeting could be a promising therapeutic avenue worth exploring following severe viral infections of the lung.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzamidesPhosphodiesterase 4 InhibitorsAminopyridinesLung InjuryAnti-Inflammatory AgentsAnimalsCyclopropanesMiceLungCytokinesInflammationSARS-CoV-2COVID-19Murine hepatitis virusDisease Models, AnimalCOVID-19 Drug TreatmentMaleChemokines

Stichwörter der Autor:innen

Anti-inflammatoryCOVID-19MHVPDE4iRoflumilastSARS-CoV-2

Substanzen

RoflumilastBenzamidesPhosphodiesterase 4 InhibitorsAminopyridinesCyclopropanesCytokinesAnti-Inflammatory AgentsChemokines

Autor:innen und Institutionen

  • Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil.
  • Departamento Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil.
  • Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil.
  • Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil.
  • Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil.
  • Departamento de Morfologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, 31270-901, Brazil. vpinhos@gmail.com.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Financiadora de Estudos e Projetos

Zitieren

APA

Beltrami, V. A., Martins, F. R. B., Martins, D. G., Queiroz-Junior, C. M., Félix, F. B., Resende, L. C., Santos, F. R. D. S., Lacerda, L. S. B., Costa, V. R. M., da Silva, W. N., Guimaraes, P. P. G., Guimaraes, G., Soriani, F. M., Teixeira, M. M., Costa, V. V., & Pinho, V. (2025). Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice. Inflammation Research, 74(1). https://doi.org/10.1007/s00011-024-01985-3

Vancouver

Beltrami VA, Martins FRB, Martins DG, Queiroz-Junior CM, Félix FB, Resende LC, et al. Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice. Inflammation Research. 2025;74(1). doi:10.1007/s00011-024-01985-3

BibTeX
@article{Beltrami2025,
  author = {Beltrami, Vinícius Amorim and Martins, Flávia Rayssa Braga and Martins, Débora Gonzaga and Queiroz-Junior, Celso Martins and Félix, Franciel Batista and Resende, Letícia Cassiano and Santos, Felipe Rocha da Silva and Lacerda, Larisse de Souza Barbosa and Costa, Victor Rodrigues de Melo and da Silva, Walison Nunes and Guimaraes, Pedro Pires Goulart and Guimaraes, Goulart and Soriani, Frederico Marianetti and Teixeira, Mauro Martins and Costa, Vivian Vasconcelos and Pinho, Vanessa},
  title = {Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice},
  journal = {Inflammation Research},
  year = {2025},
  volume = {74},
  number = {1},
  doi = {10.1007/s00011-024-01985-3}
}
Kostenlos starten →